Showing 1 - 10 of 23 results for STEM CELLS
-
Goldman Sachs | Management Committee - Stephen M. Scherr
...... Scherr serves on the board of the Jewish Museum in New York and the New York Stem Cell Foundation. ...
https://www.goldmansachs.com/our-firm/leadership/management-committee/stephen-m-scherr.html -
Goldman Sachs | Executive Officers - Stephen M. Scherr
...... Scherr serves on the board of the Jewish Museum in New York and the New York Stem Cell Foundation. ...
https://www.goldmansachs.com/our-firm/leadership/executive-officers/stephen-m-scherr.html -
Goldman Sachs | Intelligence - From Our Briefings Newsletter
...... including stem cell therapy, bioengineering, organ and tissue transplants, among other technologies -- that ... believe stem cell therapy could become the cornerstone of regenerative treatment in the future. Stem cells ......
https://www.goldmansachs.com/intelligence/pages/from_briefings_10-dec-2018.html -
Goldman Sachs | Insights - From Our Briefings Newsletter
...... including stem cell therapy, bioengineering, organ and tissue transplants, among other technologies -- that ... believe stem cell therapy could become the cornerstone of regenerative treatment in the future. Stem cells ......
https://www.goldmansachs.com/insights/pages/from_briefings_10-dec-2018.html -
Goldman Sachs | Insights - The Case for Investing in Japan
...... work in stem cells – is just one example where the private sector is helping to change this dynamic. Many ......
https://www.goldmansachs.com/insights/pages/from_briefings_28-Oct-2019.html -
Goldman Sachs | Intelligence - The Case for Investing in Japan
...... work in stem cells – is just one example where the private sector is helping to change this dynamic. Many ......
https://www.goldmansachs.com/intelligence/pages/from_briefings_28-Oct-2019.html -
COVID-19
...... ( mesenchymal stem cells) Numerous trials with Chinese research sponsors Clinical 37 of 50 Treatment (bevacizumab) ... Treatment (PLX cell product, placenta-based cell therapy) Pluristem Therapeutics/BIH Ctr for Regenerative...
https://www.goldmansachs.com/insights/talks-at-gs/sharmin-mossavar-rahmani-f/deck.pdf -
Exchanges at Goldman Sachs: Why We're in a ' Golden Age' of Life Sciences Innovation
...... immunotherapy, or stem cell based regenerative medicine. Allison Nathan: Obviously we've seen the real-life example ... germ line cells, so egg and sperm that would allow genetic modifications to be passed down to future generations....
https://www.goldmansachs.com/insights/podcasts/episodes/08-16-22-amit-sinha-f/transcript.pdf -
COVID-19
...... Antivirals Cell based therapies RNA based therapies Other Drug Screening Initatives Potential Treatments Highlights ... Mesenchymal stem cells, corticosteroids, hydroxychloroquine, Jakafi, Rebif, losartan • ~15 Treatment candidates...
https://www.goldmansachs.com/insights/talks-at-gs/04-15-2020-an-update-on-covid-19-therapies-and-vaccines-f/presentation.pdf -
Microsoft Word - _Global_Markets_Institute__Harnessing_global_capital_to_drive_the_next_phase_of_China_s_growth
...... human stem cells technologies and application ▲ 10. Water, environment and public facility management ......
https://www.goldmansachs.com/insights/pages/us-china-bilateral-investment-dialogue/multimedia/papers/gir-chinas-growth.pdf